The results of our analysis showed that ADAM12 expression was elevated in renal clear cell carcinoma, and ccRCC patients with high ADAM12 expression had significantly shorter survival than those with low ADAM12 expression. This evidence concerns the gene ADAM12 and clear cell renal carcinoma.